Navigation Links
Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer
Date:11/11/2010

ctive for larger tumors. There are few non-surgical therapeutic treatment options available as radiation therapy and chemotherapy are largely ineffective in the treatment of primary liver cancer.

About ThermoDox® and the Phase III HEAT StudyThermoDox® is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers.  In the HEAT study, ThermoDox® is administered intravenously in combination with RFA.  Localized mild hyperthermia (39.5-42 degrees Celsius) created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor.

For primary liver cancer, ThermoDox® is being evaluated in a 600 patient global Phase III study at 76 clinical sites under an FDA Special Protocol Assessment. The study is designed to evaluate the efficacy of ThermoDox® in combination with RFA when compared to patients who receive RFA alone as the control. The primary endpoint for the study is progression-free survival (PFS) with a secondary confirmatory endpoint of overall survival.  A pre-planned, unblinded interim efficacy analysis will be performed by the independent Data Monitoring Committee when enrollment in the trial is complete and 190 PFS events are realized in the study population.  Additional information on the Company's ThermoDox® clinical studies may be found at http://www.clinicaltrials.gov

About CelsionCelsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination wit
'/>"/>

SOURCE Celsion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Celsion Announces ThermoDoxs Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
2. Data Monitoring Committee Unanimously Recommends Continuation of Celsions Phase III ThermoDox® HEAT Study to Treat Primary Liver Cancer
3. Celsion Receives SBIR Grant To Expand Its Technology Platform
4. Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer
5. Celsion Announces CFO Departure
6. Stereotaxis Receives Commitment to Increase and Extend Credit Facility
7. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
8. CMUs Bone Tissue Engineering Center Receives Defense Department Research Grant to Help Injured Soldiers
9. AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System
10. Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
11. DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... 2015  Konica Minolta, Inc. (Konica Minolta) ( ... acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer ... through its Brazilian healthcare sales company, Konica Minolta Healthcare ... Brazil market investment and growth ... 200 million, significant healthcare technical advancements and efficiencies are ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION ... a new E-CUBE Series ultrasound system. Developed to enhance ... clinical areas, the E-CUBE 15 EX produces superb image ... clinical performance in women,s health, general imaging, and shared ... The latest in the renowned E-CUBE Series, the ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... ... ... After conducting a nationwide executive search led by healthcare leadership solutions ... hired Robert Trenschel, DO, as chief executive officer. A veteran physician executive with 20 ... duties at Yuma Regional Medical Center on July 13. , “Dr. Trenschel brings an ...
(Date:7/2/2015)... Dallas, TX (PRWEB) , ... July 02, 2015 ... ... and the overall status of the Gelatin Capsule manufacturers. The report is a ... industry. , The report depicts the global and Chinese market for the Gelatin ...
(Date:7/2/2015)... ... July 02, 2015 , ... Evolved ... with their launch an intention to partner with companies that share a similar ... planet. Their innovative water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are ...
(Date:7/2/2015)... AL (PRWEB) , ... July 02, 2015 , ... Every year, DUI arrests and fatalities ... July may be the deadliest day of the year when it comes to being on ... “The National Highway Traffic Safety Association reports that 40% of all highway deaths between 2007 ...
Breaking Medicine News(10 mins):Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:Attorney David Maloney Stresses Safety through Sobriety 2
... , FRIDAY, Sept. 2 (HealthDay News) -- Climate ... departments in the next decade. The prediction was ... regional and atmospheric models. They linked N.Y. State Department ... on asthma-related emergency department visits by children in 14 ...
... to predict which heart transplant patients are at greatest risk ... could help medical teams figure out who would benefit most ... are a limited resource," says John V. Conte, M.D., a ... Medicine and the senior author of the study. "Now, we ...
... News) -- Researchers using scanning technology say they discovered ... autism compared to those of kids without autism. ... children with 92 percent accuracy," based on the volume ... Lucina Uddin, first author of a new study and ...
... (HealthDay News) -- A rapid rise in hookah use in California ... water pipe used for smoking tobacco. An analysis of state data ... more than 40 percent between 2005 and 2008. In 2008, ... higher (24.5 percent of men, 10 percent of women) than it ...
... (HealthDay News) -- Traffic safety should be among a child,s first ... in the United States, more than 25,000 pedestrians aged 5 to ... and Prevention. "Kids who are struck by cars are among ... Because of their height, when a car hits a child, the ...
... Ian Roberts, Head of the World Health Organisation Collaborating Centre ... Tropical Medicine, the recent episode ("Big Lies, Small Lies") seriously ... VIIa (the drug presented in the programme) was shown to ... clotting but it has never been shown to save lives. ...
Cached Medicine News:Health News:Researchers develop new way to predict heart transplant survival 2Health News:Brain Scans Show Distinct Traits in Kids With Autism: Study 2Health News:Hookah Use Growing Among Young Adults in California 2Health News:Traffic Safety Should Be Among First Lessons in New School Year 2Health News:Trauma experts criticize BBC's Holby City for 'peddling dangerous drugs' 2
... The quanTtest human protein standards are available ... 100 and 200 mg/dL and are packaged ... liquid, ready-to-use, requiring no reconstitution or dilution ... using purified human albumin and human globulin ...
... binding method provides a simple, ready-to-use ... with greater linearity, using microliter samples ... in manual or automated systems. Assay ... 2, 3, 4 & 5), reagents, ...
... This control is intended as a ... testing methods. A new feature is ... CRP. It is compatible with most ... ACS:180, Access, Dimension, Elecsys, Stratus and ...
The Clearblue Easy Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the 2 best ...
Medicine Products: